...
首页> 外文期刊>International immunopharmacology >Inhibitory effects of flavonoids extracted from licorice on lipopolysaccharide-induced acute pulmonary inflammation in mice.
【24h】

Inhibitory effects of flavonoids extracted from licorice on lipopolysaccharide-induced acute pulmonary inflammation in mice.

机译:从甘草中提取的黄酮类化合物对脂多糖诱导的小鼠急性肺部炎症的抑制作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Airway inflammation plays important roles in the pathogenesis of acute respiratory distress syndrome (ARDS), asthma and chronic obstructive pulmonary disease (COPD), and anti-inflammatory treatment effectively improves the symptoms of these diseases. To develop the potentially therapeutic compounds for the treatment of pulmonary inflammation, we investigated the effects of licorice flavonoids (LF) extracted from the roots of Glycyrrhiza uralensis (licorice) on lipopolysaccharide (LPS)-induced acute pulmonary inflammation in mice. Acute pulmonary inflammation was induced by intracheal instillation with LPS, treatment with LF at dosages of 3, 10 and 30 mg/kg significantly reduced the LPS-induced inflammatory cells, including neutrophils, macrophages and lymphocytes accumulation in bronchoalveolar lavage fluids (BALF), among these inflammatory cells, LF predominately inhibited neutrophil infiltration, and the maximal effect (30 mg/kg) was as comparable as dexamethasone treatment at 1 mg/kg. Consistent with its effects on neutrophil infiltration, LF treatment significantly increased LPS-induced BALF superoxide dismutase activity, and significantly decreased lung myeloperoxidase activity as well. Furthermore, treatment with LF at 30 mg/kg significantly reduced LPS-induced lung TNFalpha and IL-1beta mRNA expression at 6 h and 24 h after LPS instillation, respectively. Finally, LF at different dosages not only significantly decreased the elevation of lung water content, but also markedly attenuated LPS-induced histological alteration. Therefore, we suggest that LF effectively attenuates LPS-induced pulmonary inflammation through inhibition of inflammatory cells infiltration and inflammatory mediator release which subsequently reduces neutrophil recruitment into lung and neutrophil-mediated oxidative injury, and this study provides with the potential rationale for development of anti-inflammatory compounds from flavonoid extracts of licorice.
机译:气道炎症在急性呼吸窘迫综合征(ARDS),哮喘和慢性阻塞性肺疾病(COPD)的发病机理中起着重要作用,而抗炎治疗有效地改善了这些疾病的症状。为了开发潜在的治疗化合物,用于治疗肺部炎症,我们研究了从甘草(甘草)的根中提取的甘草黄酮(LF)对脂多糖(LPS)诱导的小鼠急性肺部炎症的影响。经气管内滴注LPS可诱发急性肺部炎症,以3、10和30 mg / kg的剂量LF处理可显着减少LPS诱导的炎症细胞,包括嗜中性粒细胞,巨噬细胞和淋巴细胞在支气管肺泡灌洗液(BALF)中的积累这些炎症细胞,LF主要抑制中性粒细胞浸润,最大作用(30 mg / kg)与地塞米松1 mg / kg的作用相当。与其对中性粒细胞浸润的影响一致,LF治疗显着增加了LPS诱导的BALF超氧化物歧化酶活性,同时也显着降低了肺髓过氧化物酶活性。此外,以30 mg / kg的LF处理分别在LPS滴注后6 h和24 h显着降低LPS诱导的肺TNFalpha和IL-1beta mRNA表达。最后,不同剂量的LF不仅显着降低了肺水含量的升高,而且显着减弱了LPS诱导的组织学改变。因此,我们建议LF通过抑制炎性细胞浸润和炎性介质释放来有效减轻LPS诱导的肺部炎症,从而减少中性粒细胞向肺的募集和中性粒细胞介导的氧化损伤,这项研究为开发抗-PS药物提供了潜在的理由。甘草类黄酮提取物中的炎症化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号